Clinical features, anti-cancer treatments and outcomes of lung cancer patients with combined pulmonary fibrosis and emphysema

Lung Cancer

Volumn 85, Issue 2, 2014, Pages 258-263

  Minegishi, Yuji ^a   Kokuho, Nariaki ^a   Miura, Yukiko ^a   Matsumoto, Masaru ^a   Miyanaga, Akihiko ^a   Noro, Rintaro ^a   Saito, Yoshinobu ^a   Seike, Masahiro ^a   Kubota, Kaoru ^a   Azuma, Arata ^a   Kida, Kouzui ^a   Gemma, Akihiko ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

Acute exacerbation; Chemotherapy; Combined pulmonary fibrosis and emphysema; Emphysema; Idiopathic interstitial pneumonias; Interstitial lung disease; Lung cancer

Indexed keywords

CARBOPLATIN; ETOPOSIDE; PACLITAXEL; PLATINUM; ANTINEOPLASTIC AGENT;

ACUTE DISEASE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER PROGNOSIS; CANCER THERAPY; CLINICAL FEATURE; DISEASE EXACERBATION; FEMALE; HUMAN; HUMAN TISSUE; INTERSTITIAL PNEUMONIA; LUNG CANCER; LUNG EMPHYSEMA; LUNG FIBROSIS; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL SCHOOL; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; CANCER STAGING; COMPLICATION; DISEASE COURSE; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PROGNOSIS; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RISK FACTOR; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; DISEASE PROGRESSION; FEMALE; HUMANS; IDIOPATHIC INTERSTITIAL PNEUMONIAS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PULMONARY EMPHYSEMA; PULMONARY FIBROSIS; RETROSPECTIVE STUDIES; RISK FACTORS; TREATMENT OUTCOME;

EID: 84904104113     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2014.05.016     Document Type: Article

References (27)

1. Turner-Warwick M., Lebowits M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980, 35:496-499.
2. Panos R.J., Mortenson R.L., Niccoli S.A., King T.E. Clinical deterioration in patients with idiopathic pulmonary fibrosis: caused and assessment. Am J Med 1990, 88:396-404.
3. Hubbard R., Venn A., Lewis S., Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med 2000, 161:5-8.
4. Park J., Kim D.S., Shim T.S., Lim C.M., Koh Y., Lee S.D., et al. Lung cancer in patients with idiopathic pulmonary fibrosis. Eur Respir J 2001, 17:1216-1219.
5. American Thoracic Society/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 2002, 165:277-304.
6. Minegishi Y., Sudoh J., Kuribayashi H., Mizutani H., Seike M., Azuma A., et al. The safety and efficacy of weekly paclitaxel in combination with carboplatin for advanced non-small cell lung cancer with idiopathic interstitial pneumonias. Lung Cancer 2011, 71:70-74.
7. Minegishi Y., Kuribayashi H., Kitamura K., Mizutani H., Kosaihira S., Okano T., et al. The feasibility study of carboplatin plus etoposide for advanced small-cell lung cancer with idiopathic interstitial pneumonias. J Thorac Oncol 2011, 6:801-807.
8. Cottin V., Nuns H., Billet P.Y., Delaval P., Devouassoux G., Tillie-Leblond I., et al. Combined pulmonary fibrosis and emphysema: a distinct underrecognised entity. Eur Respir J 2005, 26:586-593.
9. Kitaguchi Y., Fujimoto K., Hanaoka M., Kawakami S., Honda T., Kubo K. Clinical characteristics of combined pulmonary fibrosis and emphysema. Respirology 2010, 15:265-271.
10. Kurashima K., Takayanagi N., Tsuchiya N., Kanauchi T., Ueda M., Hoshi T., et al. The effect of emphysema on lung function and survival in patients with idiopathic pulmonary fibrosis. Respirology 2010, 15:843-848.
11. Usui K., Tanai C., Tanaka Y., Noda H., Ishihara T. The prevalence of pulmonary fibrosis combined with emphysema in patients with lung cancer. Respirology 2011, 16:326-331.
12. Mejia M., Carrillo G., Rojas-Serrano J., Estrada A., Suárez T., Alonso D., et al. Idiopathic pulmonary fibrosis and emphysema: decreased survival associated with severe pulmonary arterial hypertension. Chest 2009, 136:10-15.
13. Ryerson C.J., Hartman T., Elicker B.M., Ley B., Lee J.S., Abbriti M., et al. Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 2013, 144:234-240.
14. Todd N.W., Jeudy J., Lavania S., Franks T.J., Galvin J.R., Deepak J., et al. Centrilobular emphysema combined with pulmonary fibrosis results in improved survival. Fibrogen Tissue Reoair 2009, 103:1209-1215.
15. Akagi T., Matsumoto T., Harada T., Tanaka M., Kuraki T., Fujita M., et al. Coexistent emphysema delays the decrease of vital capacity in idiopathic pulmonary fibrosis. Respir Med 2009, 103:1209-1245.
16. Raghu G., Mageto Y.M., Lockhart D., Schmidt R.A., Wood D.E., Godwin J.D. The accuracy of the clinical diagnosis of new-onset idiopathic pulmonary fibrosis and other inteistitial lung disease: a prospective study. Chest 1999, 116:1168-1174.
17. Nishimura K., Kitaichi M., Izumi T., Nagai S., Kanaoka M., Itoh H. Usual interstitial pneumonia: histologic correlation with high-resolution CT. Radiology 1992, 182:337-342.
18. Johkoh T., Muller N.L., Cartier Y., Kavanagh P.V., Hartman T.E., Akira M., et al. Idiopathic interstitial pneumonias: diagnostic accuracy of thin-section CT in 129 patients. Radiology 1999, 211:555-560.
19. Kondoh Y., Taniguchi H., Kawabata Y., Yokoi T., Suzuki K., Takagi K. Acute exacerbation in idiopathic pulmonary fibrosis: analysis of clinical and pathological findings in three cases. Chest 1993, 103:1808-1812.
20. Akira M., Hamada H., Sakatani M., Kobayashi C., Nishioka M., Yamamoto S., et al. CT findings during phase of accelerated deterioration in patients with idiopathic pulmonary fibrosis. Am J Roentgenol 1997, 168:79-83.
21. Minegishi Y., Takenaka K., Mizutani H., Sudoh J., Noro R., Okano T., et al. Exacerbation of idiopathic interstitial pneumonias associated with lung cancer therapy. Intern Med 2009, 48:665-672.
22. Goddard P.R., Nicholson E.M., Laszlo G., Watt I. Computed tomography in pulmonary emphysema. Clin Radiol 1982, 33:379-387.
23. Kazerooni E.A., Martinez F.J., Flint A., Jamadar D.A., Gross B.H., Spizarny D.L., et al. Thin-section CT obtained at 10-mm increments versus limited three-level thin-section CT for idiopathic pulmonary fibrosis: correlation with pathologic scoring. AJR Am J Roentgenol 1997, 169:977-983.
24. Copley S.J., Wells A.U., Sivakumaran P., Rubens M.B., Newman Taylor A.J., Rudd R.M., et al. Asbestosis and idiopathic pulmonary fibrosis: comparison of thin-section CT features. Radiology 2003, 229:731-736.
25. Schmidt S.L., Nambiar A.M., Tayob N., Sandaram B., Han M.K., Gross B.H., et al. Pulmonary function measures predict mortality differently in IPF versus combined pulmonary fibrosis and emphysema. Eur Respir J 2011, 38:176-183.
26. Jankowich M.D., Rounds S. Combined pulmonary fibrosis and emphysema alters physiology but has similar mortality to pulmonary fibrosis without emphysema. Lung 2010, 188:365-373.
27. Lee C.H., Kim H.J., Park C.M., Lim K.Y., Lee J.Y., Kim D.J., et al. The impact of combined pulmonary fibrosis and emphysema on mortality. Int Tuberc Lung Dis 2011, 15:1111-1116.